- Investing Ideas
- Belgian Pharmaceuticals & Biotech Most Popular Stocks
Belgian Pharmaceuticals & Biotech Most Popular Stocks
Results
7
Most Popular Stocks on the market
7 companies
argenx
Market Cap: €50.6b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€813.00
7D
3.5%
1Y
74.5%
UCB
Market Cap: €48.4b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€254.40
7D
-3.5%
1Y
49.7%
Financière de Tubize
Market Cap: €9.7b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€218.60
7D
-5.0%
1Y
61.7%
Hyloris Pharmaceuticals
Market Cap: €125.4m
Operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific.
HYL
€4.48
7D
-3.4%
1Y
-28.7%
Celyad Oncology
Market Cap: €10.2m
A biotechnology company, focuses on unlocking the potential of its intellectual property.
CYAD
€0.23
7D
-1.7%
1Y
-35.4%
BioSenic
Market Cap: €1.3m
A biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France.
BIOS
€0.002
7D
0%
1Y
-13.0%
Oxurion
Market Cap: €248.3k
A biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium.
OXUR
€0.0028
7D
-6.7%
1Y
-89.9%